If you need more lookups,
subscriptions start at $34 USD/month.
Drew Wightman Location
London, GB
Drew Wightman Work
Head of Deal Finance and M and A (Oncology, Rare Disease) @ (January 2025 - Present)
Managing Director, Investment Banking @ (October 2022 - December 2024)
Senior Director, Deal Finance and M and A @ (September 2015 - September 2022)
Assistant Director, EY Corporate Finance @ (November 2006 - August 2015)
Auditor @ (September 2003 - November 2006)
Drew Wightman Education
ICAEW
ACA
2003-2006
University of York
MSc (Finance)
2002-2003
Alliance Manchester Business School
BSc (Hons) (Management)
1998-2001
Drew Wightman Skills
Biopharmaceuticals
Biotechnology
Business Development
Corporate Finance
Divestitures
Investments
Mergers & Acquisitions
Portfolio Management
Private Equity
Restructuring
Strategy
Valuation
Auditing
Financial Reporting
Accountants
Research
Finance
Mergers and Acquisitions
Assistant Director
Customer Service
Talent Acquisition
Recruiting
Strategic Planning
Drew Wightman Summary
Drew Wightman, based in London, GB, is currently a Head of Deal Finance and M and A (Oncology, Rare Disease) at AstraZeneca. Drew Wightman brings experience from previous roles at Alantra, AstraZeneca, Ernst & Young and Deloitte. Drew Wightman holds a 2003 - 2006 ACA @ ICAEW. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Corporate Finance, Divestitures and more. Drew Wightman has 1 emails on RocketReach.
Looking for a different Drew Wightman?
Find contact details for 700 million professionals.